- Home
- ADGM
as 12-18-2024 4:00pm EST
Stocks
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | LAGUNA HILLS |
| Market Cap: | 33.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 52.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.69 - $9.34 | Next Earning Date: | 11-14-2024 |
| Revenue: | $543,000 | Revenue Growth: | 187.30% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ADAGIO MEDICAL HOLDINGS INC News
ADGM Breaking Stock News: Dive into ADGM Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
Simply Wall St.
a month ago
Adagio Medical Holdings Reports Third Quarter 2024 Earnings
Business Wire
a month ago
Adagio Medical Reports Third Quarter 2024 Results
Business Wire
a month ago
Adagio Medical to Present at the Stifel 2024 Healthcare Conference
Business Wire
2 months ago
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
Business Wire
2 months ago
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
Business Wire
4 months ago
Adagio Medical Provides Business Updates
Compare ADGM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADGM ADAGIO MEDICAL HOLDINGS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.